DiscoverPulmPEEPs81. RFJC 12 – ARDS Series – PROSEVA
81. RFJC 12 – ARDS Series – PROSEVA

81. RFJC 12 – ARDS Series – PROSEVA

Update: 2024-08-14
Share

Description

In this podcast episode, we continue our summer series reviewing landmark ARDS studies. Today, Dave and Luke discuss the PROSEVA trial (published in NEJM in 2013) which evaluated the impact of early, prolonged proning in patients with severe ARDS.





<figure class="wp-block-image size-large"></figure>



<figure class="wp-block-image size-large is-resized"></figure>



Article and Reference





We are talking about the PROSEVA trial today which evaluated the patients with severe ARDS (P/F < 150) to undergo prone-positioning sessions of at least 16 hours or to be left in the supine position.





Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, Clavel M, Chatellier D, Jaber S, Rosselli S, Mancebo J, Sirodot M, Hilbert G, Bengler C, Richecoeur J, Gainnier M, Bayle F, Bourdin G, Leray V, Girard R, Baboi L, Ayzac L; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013 Jun 6;368(23):2159-68. doi: 10.1056/NEJMoa1214103. Epub 2013 May 20. PMID: 23688302.





Infographic





<figure class="wp-block-image size-large"></figure>
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

81. RFJC 12 – ARDS Series – PROSEVA

81. RFJC 12 – ARDS Series – PROSEVA

Pulm PEEPs